![Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy | SpringerLink Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00424-021-02623-1/MediaObjects/424_2021_2623_Fig4_HTML.png)
Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy | SpringerLink
![Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy | springermedizin.de Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy | springermedizin.de](https://media.springernature.com/lw400/springer-static/cover/journal/10072/43/2S.jpg?as=jpg)
Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy | springermedizin.de
![Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management - The Lancet Neurology Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management - The Lancet Neurology](https://www.thelancet.com/cms/attachment/d52959d9-5910-47d9-afa5-dc98bb675f38/gr3_lrg.jpg)
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management - The Lancet Neurology
![Biomedicines | Free Full-Text | The PKA-p38MAPK-NFAT5-Organic Osmolytes Pathway in Duchenne Muscular Dystrophy: From Essential Player in Osmotic Homeostasis, Inflammation and Skeletal Muscle Regeneration to Therapeutic Target Biomedicines | Free Full-Text | The PKA-p38MAPK-NFAT5-Organic Osmolytes Pathway in Duchenne Muscular Dystrophy: From Essential Player in Osmotic Homeostasis, Inflammation and Skeletal Muscle Regeneration to Therapeutic Target](https://www.mdpi.com/biomedicines/biomedicines-09-00350/article_deploy/html/images/biomedicines-09-00350-g001.png)
Biomedicines | Free Full-Text | The PKA-p38MAPK-NFAT5-Organic Osmolytes Pathway in Duchenne Muscular Dystrophy: From Essential Player in Osmotic Homeostasis, Inflammation and Skeletal Muscle Regeneration to Therapeutic Target
![Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management - The Lancet Neurology Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management - The Lancet Neurology](https://www.thelancet.com/cms/attachment/2119157796/2089927075/gr1.jpg)
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management - The Lancet Neurology
![PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6158244cf773e6d075e905b9795eff228c762451/5-Figure2-1.png)
PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar
![Lower Extremity Functional Outcome Measures in Duchenne Muscular Dystrophy-A Delphi Survey - IOS Press Lower Extremity Functional Outcome Measures in Duchenne Muscular Dystrophy-A Delphi Survey - IOS Press](https://content.iospress.com/media/jnd/2019/6-1/jnd-6-1-jnd180337/jnd-6-jnd180337-g001.jpg)
Lower Extremity Functional Outcome Measures in Duchenne Muscular Dystrophy-A Delphi Survey - IOS Press
![PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6158244cf773e6d075e905b9795eff228c762451/11-Figure6-1.png)
PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar
![The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy | Journal of the American Heart Association The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/63f04c3f-688c-4f06-a4a1-bc0378698594/jah36800-fig-0001.png)
The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy | Journal of the American Heart Association
![PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6158244cf773e6d075e905b9795eff228c762451/7-Figure3-1.png)
PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar
![Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management - ScienceDirect Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1474442218300255-gr5.jpg)
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management - ScienceDirect
![Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy | Science Translational Medicine Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abo1815/asset/dcb58758-0e4a-48e3-963a-aba639ab6b6c/assets/images/large/scitranslmed.abo1815-f1.jpg)
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy | Science Translational Medicine
![Clinical Follow‐Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal - Kwon - 2016 - Muscle & Nerve - Wiley Online Library Clinical Follow‐Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal - Kwon - 2016 - Muscle & Nerve - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4fba09b9-4461-4455-b018-6f2d27b0f378/mus.v54.2.cover.jpg?trick=1669011205259)
Clinical Follow‐Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal - Kwon - 2016 - Muscle & Nerve - Wiley Online Library
![Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management - ScienceDirect Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1474442218300255-gr2.jpg)
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management - ScienceDirect
![Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks - ScienceDirect Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661820312251-ga1.jpg)
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks - ScienceDirect
![Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management - The Lancet Neurology Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management - The Lancet Neurology](https://www.thelancet.com/cms/attachment/2119219869/2090782688/gr1.jpg)
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management - The Lancet Neurology
![Cells | Free Full-Text | Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy Cells | Free Full-Text | Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy](https://pub.mdpi-res.com/cells/cells-07-00253/article_deploy/html/images/cells-07-00253-ag.png?1570799751)